🇺🇸 FDA
Patent

US 11992519

Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

granted A61KA61K2239/48A61K31/675

Quick answer

US patent 11992519 (Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2239/48, A61K31/675, A61K31/7076, A61K40/11